A multi-specific, multi-affinity antibody platform neutralizes sarbecoviruses and confers protection against SARS-CoV-2 in vivo – Science

1. A multi-specific, multi-affinity antibody platform neutralizes sarbecoviruses and confers protection against SARS-CoV-2 in vivo Science
2. Nucleocapsid-specific T cell responses associate with control of SARS-CoV-2 in the upper airways before seroconversion Nature.com
3. Drugs that Covid & flu viruses can’t resist found Indiatimes.com
4. New Indian drug candidates to fight existing as well as emerging Covid strains and influenza Deccan Herald
5. Coronavirus spike protein-specific antibodies indicate frequent infections and reinfections in infancy and among BNT162b2-vaccinated healthcare workers | Scientific Reports Nature.com
6. View Full Coverage on Google News

Read original article here